health technology Genmab Q4 2025 Earnings Report: Innovation Push Drives Profit Surge 4 weeks ago Genmab A/S (Nasdaq: GMAB) released its full-year 2025 financial results, demonstrating the company's improved operational execution. Total revenue reached $3.72… InMode shares move after fourth-quarter revenue growth and full-year decline 1 month ago InMode Ltd (NASDAQ: INMD) reported its financial results for the fourth quarter and full year ended December 31, 2025, showing… Zimmer Biomet shares climb after fourth-quarter sales and earnings growth 1 month ago Zimmer Biomet Holdings, Inc. (NYSE: ZBH) closed at $93.60, up 4.3% on the day, after reporting fourth-quarter and full-year 2025… Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026 1 month ago Roivant Sciences (Nasdaq: ROIV) reported its financial results for the fiscal third quarter ended December 31, 2025, underscored by positive… Roivant Sciences Reports Fiscal Third Quarter 2025 Results Amid Robust Pipeline Advancement 1 month ago Roivant Sciences (Nasdaq: ROIV) on Friday reported its financial results for the fiscal third quarter ended December 31, 2025, revealing…